デフォルト表紙
市場調査レポート
商品コード
1347593

糖尿病ケア機器市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Diabetes Care Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
糖尿病ケア機器市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要:

世界の糖尿病ケア機器市場規模は2022年に296億米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に7.9%の成長率(CAGR)を示し、2028年までに473億米ドルに達すると予測しています。

糖尿病ケア機器とは、血糖値の監視や測定に使用される機器を指します。スマートインスリンペン、グルコメーター、ケトン、持続グルコースモニター(CGM)、インスリンポンプ、糖尿病管理アプリケーションは、一般的な糖尿病ケア機器の一部です。これらはランセット、グルコースセンサー、モニター、ドッキングステーション、テストプラグ、テストストリップで構成され、糖尿病の状態を常にモニターするのに役立ちます。糖尿病ケア機器は、血液中のグルコース吸収量に影響を及ぼす慢性疾患である糖尿病の診断とモニタリングに広く使用されています。その結果、これらの機器は血糖値を正確に把握し、糖尿病治療の効果を判定し、高血糖や低血糖の発生を抑えるのに役立っています。

糖尿病ケア機器市場の動向:

糖尿病の有病率の増加、特に世界中で着実に増加している老年人口の増加が、市場に明るい見通しをもたらしています。糖尿病ケア機器は、呼吸器疾患、腎不全、肝不全、心血管疾患など、糖尿病に関連する症状や合併症の治療・管理に広く採用されています。これに伴い、より良いケアと病気の管理のために、グルコースモニタリングとインスリン送達デバイスが広く利用されていることが、市場の成長を後押ししています。これとは別に、患者の症状やバイオマーカーの遠隔モニタリングを可能にする人工知能(AI)、機械学習(ML)、モノのインターネット(IoT)と統合されたスマート糖尿病デバイスのイントロダクションが市場成長に弾みをつけています。さらに、患者の動的な血糖プロファイルに関する情報を含む血糖自己測定(SMBG)の需要の増加が、市場成長にプラスの影響を与えています。さらに、食事、活動、投薬の適切なスケジューリングに役立つため、糖尿病の治療において価値あるツールとなっています。その他の要因としては、広範な研究開発(R&D)活動、進化する食習慣と座りがちなライフスタイル、より良い健康サービスの提供に焦点を当てた様々な政府イニシアチブの実施などが挙げられ、これらは市場の成長に向けた原動力になると予想されます。

本レポートで扱う主な質問

  • 世界の糖尿病ケア機器市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • COVID-19が世界の糖尿病ケア機器市場に与えた影響は?
  • 主要地域市場は?
  • タイプ別の市場内訳は?
  • 販売チャネル別の市場内訳は?
  • エンドユーザー別の市場内訳は?
  • 業界のバリューチェーンにおける様々な段階とは?
  • 業界の主な促進要因と課題は何か?
  • 世界の糖尿病ケア機器市場の構造と主要プレイヤーは?
  • 業界の競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の糖尿病ケア機器市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:タイプ別

  • 血糖モニタリング(BGM)機器
    • 市場動向
    • 主要セグメント
      • セルフモニタリング機器
      • 持続血糖モニタリング機器
    • 市場予測
  • インスリン送達デバイス
    • 市場動向
    • 主要セグメント
      • ポンプ
      • ペン
      • シリンジ
      • ジェットインジェクター
    • 市場予測

第7章 市場内訳:流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • 糖尿病クリニック/センター
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 在宅ケア
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測

第9章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • ACON Laboratories Inc.
    • Ascensia Diabetes Care Holdings AG(PHC Holdings Corporation)
    • Becton Dickinson and Company
    • Bionime Corporation
    • Dexcom Inc.
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Medtronic plc
    • Novo Nordisk A/S
    • Sinocare Inc.
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Diabetes Care Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetes Care Devices Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Diabetes Care Devices Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Diabetes Care Devices Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Diabetes Care Devices Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Diabetes Care Devices Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Diabetes Care Devices Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Diabetes Care Devices (Insulin Delivery Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Diabetes Care Devices (Insulin Delivery Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Diabetes Care Devices (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Diabetes Care Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Diabetes Care Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Diabetes Care Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Diabetes Care Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Diabetes Care Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Diabetes Care Devices (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Diabetes Care Devices (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Diabetes Care Devices (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Diabetes Care Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Diabetes Care Devices (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Diabetes Care Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Diabetes Care Devices (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Diabetes Care Devices (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Diabetes Care Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Diabetes Care Devices Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Diabetes Care Devices Industry: SWOT Analysis
  • Figure 80: Global: Diabetes Care Devices Industry: Value Chain Analysis
  • Figure 81: Global: Diabetes Care Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetes Care Devices Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Diabetes Care Devices Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Diabetes Care Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Diabetes Care Devices Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Diabetes Care Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Diabetes Care Devices Market: Competitive Structure
  • Table 7: Global: Diabetes Care Devices Market: Key Players
目次
Product Code: SR112023A5746

Market Overview:

The global diabetes care devices market size reached US$ 29.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 47.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2023-2028.

Diabetes care devices refer to equipment used to monitor or determine blood sugar levels. Smart insulin pens, glucometers, ketone, continuous glucose monitors (CGMs), insulin pumps and diabetes management applications are some of the common diabetes care devices. They consist of lancets, glucose sensors, monitors, docking stations, test plugs and test strips that help constantly monitor diabetic conditions. Diabetes care devices are widely used to diagnose and monitor diabetes mellitus, a chronic disorder that affects the amount of glucose absorption in the blood. Consequently, these devices assist in accurately identifying blood sugar levels, determining the effectiveness of diabetes treatment, and lowering the instances of hyperglycemia and hypoglycemia.

Diabetes Care Devices Market Trends:

The growing prevalence of diabetes, especially amongst the steadily rising geriatric population across the globe, is creating a positive outlook for the market. Diabetes care devices are widely adopted to treat and manage symptoms and complications associated with the disorder, such as respiratory issues, kidney and liver failure, and cardiovascular conditions. In line with this, the extensive utilization of glucose monitoring and insulin delivery devices for better care and management of the disease is favoring the market growth. Apart from this, the introduction of smart diabetes devices integrated with artificial intelligence (AI), machine learning (ML) and the Internet of Things (IoT) to enable remote monitoring of the patient's symptoms and biomarkers are providing an impetus to the market growth. Additionally, the increasing demand for self-monitoring of blood glucose (SMBG) that includes information regarding the patient's dynamic blood glucose profile is positively impacting the market growth. The reading further aids in the appropriate scheduling of food, activity, and medication, thus making them a valueable tool in the treatment of diabetes mellitus. Other factors, including extensive research and development (R&D) activities, evolving eating habits and sedentary lifestyles, and the implementation of various government initiatives focusing on providing better health services are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global diabetes care devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, distribution channel and end user.

Breakup by Type:

Blood Glucose Monitoring (BGM) Devices

Self-Monitoring Devices

Continuous Glucose Monitoring Devices

Insulin Delivery Devices

Pumps

Pens

Syringes

Jet Injectors

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Diabetes Clinics/Centers

Online Pharmacies

Others

Breakup by End User:

Hospitals

Homecare

Diagnostic Centers

Ambulatory Surgery Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, ACON Laboratories Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation), Becton Dickinson and Company, Bionime Corporation, Dexcom Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Sinocare Inc. and Terumo Corporation.

Key Questions Answered in This Report:

  • How has the global diabetes care devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global diabetes care devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global diabetes care devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetes Care Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Blood Glucose Monitoring (BGM) Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Self-Monitoring Devices
      • 6.1.2.2 Continuous Glucose Monitoring Devices
    • 6.1.3 Market Forecast
  • 6.2 Insulin Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Pumps
      • 6.2.2.2 Pens
      • 6.2.2.3 Syringes
      • 6.2.2.4 Jet Injectors
    • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes Clinics/Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Online Pharmacies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgery Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ACON Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bionime Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Dexcom Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Medtronic plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinocare Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis